Subclinical atrial fibrillation patients, who are the best candidates for oral anticoagulant therapy?

Bi Huang; David J. Wright; Professor Gregory Lip

doi:10.1016/j.ejim.2024.03.015

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2014

Abstract 19998: Event Rate in Patients with Atrial Fibrillation who Discontinue Oral Anticoagulant Therapy Early: Results from the GARFIELD Registry

Shinya Goto, Frank Cools, Freek W.A. Verheugt, Toon Wei Lim, Alexander G.G. Turpie, Martin van Eickels, Gloria Kayani, Giancarlo Agnelli, Pantep Angchaisuksiri, Barry Jacobson, Ajay K. Kakkar

Article2020

Anticoagulant Therapy in Initially Low‐Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors

Sun Young Choi, Moo Hyun Kim, Kwang Min Lee, Young‐Rak Cho, Jong Sung Park, Seong Woo Kim, Jin Kyung Kim, Matthew Chung, Sung‐Cheol Yun, Professor Gregory Lip

Editorial Material2023

Sex disparities for patients with atrial fibrillation in the direct oral anticoagulant era

Hironori Ishiguchi, Yang Liu, Professor Gregory Lip

Article2016

Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project

Qinmei Xiong, Alena Shantsila, Juxiang Li, Kui Hong, Professor Gregory Lip

Article2025

Oral anticoagulant therapy for patients with atrial fibrillation on long‐term dialysis: A network meta‐analysis of 137,574 patients

Yao Du, Yan-Mei Zeng, Sixin Xu, Qiwei Shen, Jinzhu Hu, Professor Gregory Lip